The Food and Drug Administration has approved a new drug, Cobenfy, for schizophrenia that is said to have fewer side effects than current medications. This has been a major development for patients like Tiffany who have struggled with severe side effects from traditional antipsychotic drugs. Tiffany shares her personal experience and how this new medication gives her hope for a better quality of life.
Schizophrenia: New Drug Approved by FDA Offers Hope for Patients
Background
Schizophrenia is a severe mental disorder characterized by hallucinations, delusions, disorganized thinking, and social withdrawal. Antipsychotic medications have been the mainstay of treatment for schizophrenia, but they often cause significant side effects, including movement disorders, metabolic problems, and cognitive impairment.
FDA Approves New Drug for Schizophrenia
In February 2023, the US Food and Drug Administration (FDA) approved a new medication called Cobenfy (asenapine sublingual tablet) for the treatment of schizophrenia. Cobenfy is a novel antipsychotic that is designed to have fewer side effects than traditional medications.
Trials have shown that Cobenfy is effective in reducing the symptoms of schizophrenia and improving overall functioning. Unlike other antipsychotics that are given as injections or tablets, Cobenfy is administered sublingually (under the tongue), which allows for faster absorption and a potential reduction in side effects.
Patient Perspective
For patients like Tiffany, who has struggled with severe side effects from traditional antipsychotic drugs, Cobenfy offers a beacon of hope. Tiffany has experienced significant improvement in her symptoms and quality of life since starting Cobenfy.
"It's like a weight has been lifted off my shoulders," said Tiffany. "I'm able to think more clearly, I'm more social, and I'm finally starting to feel like myself again."
Top 5 FAQs
1. What are the potential benefits of Cobenfy over other antipsychotics?
Cobenfy is designed to have fewer side effects, including movement disorders, metabolic problems, and cognitive impairment.
2. How is Cobenfy administered?
Cobenfy is administered sublingually, which means it is placed under the tongue. This allows for faster absorption and a potential reduction in side effects.
3. What are the common side effects of Cobenfy?
The most common side effects of Cobenfy include headache, nausea, vomiting, dizziness, and drowsiness.
4. Is Cobenfy approved for use in all patients with schizophrenia?
While Cobenfy is generally well-tolerated, it may not be appropriate for all patients with schizophrenia. It is important to discuss your individual needs with your healthcare provider.
5. What is the long-term outlook for patients taking Cobenfy?
Studies are ongoing to determine the long-term safety and efficacy of Cobenfy. However, the short-term results have been promising, and patients like Tiffany are hopeful for a brighter future.
In a recent family vlog, Indian celebrity couple Shoaib Ibrahim and Dipika Kakar shared their "natural" hair care routine for their son, using a homemade mask made with rice flour, flax seeds, and coconut oil. However, experts warn that what works for adults may not be suitable for babies, whose sensitive skin and scalp could react to the ingredients. While the ingredients may improve hair texture, they do not necessarily promote hair growth. Instead, a healthy diet and good scalp care are more important in maintaining healthy hair.
A recent consumer study has found multiple brands of soft contact lenses in the U.S. to contain "forever chemicals" that can be harmful to both the body and the environment. The study, conducted by the nonprofit organization Environmental Health Sciences, tested 18 varieties of popular contact lenses and found all of them to contain markers for PFAS. Brands such as Acuvue, Alcon, and CooperVision were among the list of affected products. This news serves as a cautionary lesson on the potential risks of overusing contact lenses.
On the birth anniversary of Dr. APJ Abdul Kalam, the ‘Missile Man’ of India, tributes pour in on social media celebrating his life, vision and impact. A visionary scientist, inspiring leader and true patriot, Dr. Kalam's humility, compassion and constant interaction with students continue to inspire generations. His tireless efforts in defense, science and youth empowerment have strengthened India's path towards self-reliance and his legacy continues to motivate young minds to dream big and work hard for the nation.
Recent studies have found that extreme heat, particularly when combined with high humidity, can have a significant impact on mental health. A study in India showed that when wet bulb temperature exceeded 27°C, the probability of reporting severe depression increased by 0.5%, even when the temperature was slightly lower. This finding is consistent with global reviews that have linked high temperatures to mood disorders, increased hospital admissions for psychiatric conditions, and even elevated suicide risk. The Lancet has also published evidence that rising temperatures worldwide are a growing threat to emotional and cognitive health.
In a meeting with university officials in Udaipur, Rajasthan Governor Hari Bhau Bagde stressed the importance of incorporating India's ancient knowledge traditions into academic research. He highlighted the deep repository of knowledge in India since ancient times and urged scholars and scientists to draw upon this tradition in their work. Bagde also suggested making ancient texts available in university libraries for study and research purposes, in order to shape the intellectual abilities and love for the nation among the younger generation.
John Clarke, Michel H. Devoret, and John M. Martinis have been awarded the 2025 Nobel Prize in Physics for their pioneering research into quantum mechanical tunnelling. Their discovery has opened new possibilities for quantum technologies, and will be formally presented on December 10, the anniversary of Alfred Nobel's death. This announcement follows the tradition of recognizing transformative contributions to science, and the award carries a prestigious prize of 11 million Swedish kronor.
The US-Japanese trio of Mary E Brunkow, Fred Ramsdell, and Shimon Sakaguchi have won the 2025 Nobel Prize in physiology or medicine “for their discoveries concerning peripheral immune tolerance". Through their research, they have shown how the immune system is kept in check and why serious autoimmune diseases do not affect everyone. Sakaguchi found a new class of T cells, while Brunkow and Ramsdell discovered the explanation behind a specific mouse strain's vulnerability to autoimmune diseases. Together, they have significantly advanced our understanding of immunology and autoimmune diseases.
Indian astronaut Shubhanshu Shukla, who recently completed a 20-day space mission, shared his insights and experiences at the convocation ceremony of Dr. APJ Abdul Kalam Technical University. He highlighted the importance of patience, focus, and the inevitability of change in achieving success, and urged the graduating class to actively contribute to shaping a fearless and ambitious India.
The Regional Meteorological Centre (RMC) in Chennai has issued a weather alert for parts of Tamil Nadu, with thunderstorms and light to moderate rainfall expected on Saturday. The alert was issued due to the strengthening of a cyclonic circulation in the Bay of Bengal, which is likely to intensify and form a low-pressure area. The system is expected to affect Tamil Nadu, Puducherry, and Karaikal, with some areas experiencing heavy rainfall and gusty winds. The public is advised to stay updated and take precautions, especially in hilly and western districts.
As a step towards advancing India's deep-sea research capabilities, the Union Science Minister announced a landmark contract with the International Seabed Authority to conduct mineral exploration in the Indian Ocean for the next 15 years. This move will not only help India in expanding its scientific knowledge about the deep sea but also has the potential to strengthen its position as a leading player in the international seabed mining industry.